UnitedHealth: Market Misinterprets Cyclical Pressures as Structural

Stephen Dodson of Bretton Fund presented his in-depth investment thesis on UnitedHealth Group (US: UNH) at Best Ideas 2026.

Thesis summary:

UNH operates as a dominant healthcare franchise combining UnitedHealthcare, the nation’s largest insurer, with Optum, a massive healthcare services arm serving 100 million Americans. This dual structure creates a distinct competitive advantage, particularly in the shift toward Value-Based Care (VBC), where provider incentives align with patient outcomes to control costs. By owning both the insurance risk and the care delivery network (OptumHealth), the company leverages superior data and scale to drive efficiencies that pure-play competitors cannot match. The business has historically delivered consistent low-double-digit compounding in revenue and EPS, supported by high returns on capital and a diverse stream of profit pools across pharmacy benefits, data analytics, and care delivery.

The company recently faced substantial headwinds driven by a sharp, unexpected increase in healthcare utilization and an underwriting failure in its Medicare Advantage (MA) book. In 2025, the Medical Loss Ratio (MLR) spiked to near 90%, well above the historical average of 82%, as the company aggressively expanded into MA just as patient acuity and utilization rates accelerated. This mispricing was exacerbated by regulatory rate pressures and a lag effect from delayed COVID-19 treatments, leading to fears of permanently impaired earnings and causing the stock to trade at a discount relative to its history.

Stephen views these operational setbacks as cyclical and fixable rather than structural. Under the leadership of returning CEO Stephen Hemsley, management is aggressively repricing its book of business, increasing premiums on commercial plans by low double digits and ACA plans by roughly 25%. The company is also pruning unprofitable membership, projecting a loss of ~1 million MA subscribers to reset the cost base. While these actions will dampen near-term growth, they are designed to restore operating margins to the historical 8-9% range over the medium term, with the company expecting a return to regular growth by 2027.

Long-term growth remains underpinned by secular tailwinds, specifically the ongoing penetration of MA and the broader expansion of US health spending. As the industry transitions from fee-for-service to VBC—growing at 15% annually—UnitedHealth’s integrated model positions it to capture economics across the value chain. Optum’s diverse business lines, including OptumRx and OptumInsight, provide durability against volatility in the insurance underwriting cycle. Furthermore, the company maintains a shareholder-centric capital allocation strategy, consistently deploying free cash flow toward dividends and share repurchases, although buybacks have been temporarily paused to reduce leverage following the Amedisys acquisition.

Shares recently traded at roughly $341, implying a market capitalization of $310 billion and a 2.6% dividend yield. While the stock trades at approximately 21x depressed 2025 earnings of $16.32, the valuation compresses to roughly 16x estimated 2027 earnings of nearly $21 as margins recover. Stephen argues that the market is currently underwriting permanently lower margins of 5-6%, ignoring the high probability of a mean reversion to historical profitability levels. The current valuation offers a compelling entry point for a high-quality compounder temporarily dislocated by solvable underwriting errors.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

First name:

Last name:

Email address:

City / state / country:

Company:

How did you hear about MOI Global? Select Member referral Staff This website Media / Internet Other

If referral, please provide member's name:

Which of the following applies most closely to you? Select Investment Firm - Head Investment Firm - Analyst or PM Institutional Allocator - Firm C-Level Executive Institutional Allocator - Firm Employee Family Office - Head or Co-Owner Family Office - Employee Non-Investment Firm - C-Level Executive Non-Investment Firm - Employee Other

How do you hope to add value to the community?

Leave this field empty if you're human:

About the instructor:

Stephen Dodson is the president and founder of Bretton Capital Management and serves as the portfolio manager to the Bretton Fund, a mutual fund with a long-term, concentrated, value strategy. Stephen serves on the San Francisco advisory board for YIMBY Action, a housing advocacy group.

Prior to founding Bretton in 2010, he served as president, portfolio manager, and chief operating officer of Parnassus Investments, a family of mutual funds. He previously worked for the venture capital group of Advent International, a private equity firm, and was an investment banker for Morgan Stanley in New York and Menlo Park.